Innovative Bioresearch Aims To Disrupt Pharma with INNBC - CEO interview on cryptotrends.in

Great and inspiring interview with Innovative Bioresearch CEO Jonathan Fior, on how INNBC, the first and only real biotech token on the market with actual scientific publications, aims to disrupt the pharmaceutical industry introducing INNBC as a decentralized tool to fund scientific research bypassing the traditional economical conflict of interests and developing cheaper therapies for diseases such as HIV, cancer, and recently COVID19.


https://cryptotrends.in/innovative-bioresearch-aims-to-disrupt-pharma/

0 views

Content is available under CC BY-SA 3.0 unless otherwise noted.